by pbn | Jan 24, 2023 | Press Releases
Congratulations to Dr Michael Sloth Trabjerg MD, 2N Pharma Co-Founder, CSO and Aalborg University Associate Professor Dr John Dirk Vestergaard Nieland, and collaborators on the publication of their newest article in npj Parkinson’s Disease. The article details their...
by pbn | Dec 1, 2022 | Press Releases
We are so happy that WAPO published an article about the extremely interesting work being carried out by Dr Dina Dechmann, Dr Liliana Dávalos, and 2N Pharma CSO and Aalborg University associate prof. Dr John Dirk Vestergaard Nieland. In the winter, the...
by pbn | Jun 23, 2021 | Press Releases
Aalborg, Denmark, 23 June 2021 – 2N Pharma, a biotech company developing therapeutic drugs to treat neurological disorders, today announced the appointment of Alex Leech as Chair of the Board of Directors and John Kemp as Non-Executive Director. “We are...
by pbn | Jun 23, 2021 | Board of Directors
Alex Leech was the founding CEO of Alchemab Therapeutics and raised a £60m ($82m) Series A in 2021. He is a serial biotech CEO having led Creabilis, a leading European dermatology company, until its acquisition by Sienna Biopharmaceuticals Inc. in December 2016 and...
by pbn | Jun 23, 2021 | Board of Directors
John Kemp is currently the CSO of Syndesi Therapeutics. Former roles include Head of Neuroscience Discovery at Janssen, Belgium, and CEO of Evotec Neurosciences, which was spun-out from Evotec and raised a €25m Series A in 2004. Before joining Evotec, John was SVP and...
Recent Comments